Shapiro R - Search Results

1

Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.

Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, Berger M. Jolles S, et al. Among authors: shapiro r. Clin Exp Immunol. 2015 Feb;179(2):146-60. doi: 10.1111/cei.12485. Clin Exp Immunol. 2015. PMID: 25384609 Free PMC article. Review.

2

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies.

Borte M, Bernatowska E, Ochs HD, Roifman CM; Vivaglobin Study Group. Borte M, et al. Clin Exp Immunol. 2011 Jun;164(3):357-64. doi: 10.1111/j.1365-2249.2011.04376.x. Epub 2011 Mar 17. Clin Exp Immunol. 2011. PMID: 21413943 Free PMC article.

3

Subcutaneous immunoglobulin: opportunities and outlook.

Misbah S, Sturzenegger MH, Borte M, Shapiro RS, Wasserman RL, Berger M, Ochs HD. Misbah S, et al. Among authors: shapiro rs. Clin Exp Immunol. 2009 Dec;158 Suppl 1(Suppl 1):51-9. doi: 10.1111/j.1365-2249.2009.04027.x. Clin Exp Immunol. 2009. PMID: 19883424 Free PMC article. Review.

4

7th International Immunoglobulin Conference: Immunoglobulin in clinical practice.

Shapiro RS, Borte M. Shapiro RS, et al. Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):65-6. doi: 10.1111/cei.12515. Clin Exp Immunol. 2014. PMID: 25546766 Free PMC article. Review.

5

7th International Immunoglobulin Conference: Immunoglobulin in clinical practice.

Shapiro RS, Borte M. Shapiro RS, et al. Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):86. doi: 10.1111/cei.12522. Clin Exp Immunol. 2014. PMID: 25546773 Free PMC article.

6

Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes.

Shapiro RS, Wasserman RL, Bonagura V, Gupta S. Shapiro RS, et al. J Clin Immunol. 2017 Feb;37(2):190-196. doi: 10.1007/s10875-014-9990-x. Epub 2014 Jan 30. J Clin Immunol. 2017. PMID: 24477950 Review.

7

Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push.

Shapiro R. Shapiro R. Clin Exp Immunol. 2013 Aug;173(2):365-71. doi: 10.1111/cei.12099. Clin Exp Immunol. 2013. PMID: 23607310 Free PMC article.

8

Subcutaneous immunoglobulin therapy by rapid push is preferred to infusion by pump: a retrospective analysis.

Shapiro R. Shapiro R. J Clin Immunol. 2010 Mar;30(2):301-7. doi: 10.1007/s10875-009-9352-2. Epub 2010 Jan 15. J Clin Immunol. 2010. PMID: 20082124

9

Why I use subcutaneous immunoglobulin (SCIG).

Shapiro RS. Shapiro RS. J Clin Immunol. 2013 Jan;33 Suppl 2:S95-8. doi: 10.1007/s10875-012-9853-2. Epub 2012 Dec 21. J Clin Immunol. 2013. PMID: 23264027 Review.

10

Payor issues: barriers to optimal management of patients with primary immunodeficiency.

Shapiro RS, Boyle M. Shapiro RS, et al. J Clin Immunol. 2012 Sep;32 Suppl 2:S410-4. doi: 10.1007/s10875-012-9759-z. Epub 2012 Aug 25. J Clin Immunol. 2012. PMID: 22918575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,225 results

Search Page

Filters